EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparison of agar-based methodologies to broth disc elution for the detection of aztreonam susceptibility in the presence of ceftazidime-avibactam

Teslin S Sandstrom iD, Andra Banete iD, Alice Kanyua iD, Kevin M Davis, Susan M Poutanen iD

Microbiology Spectrum · 07.04.2026 · 14 (4)

DOI: 10.1128/spectrum.03794-25 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Microbiology Spectrum, erschienen am 07.04.2026. Verfasst von Teslin S Sandstrom und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathobiology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Ceftazidime, Aztreonam, Azabicyclo Compounds, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The combination of aztreonam and ceftazidime-avibactam is a proven treatment option for infections caused by metallo-beta-lactamase (MBL)-expressing gram-negative organisms. Restoration of aztreonam susceptibility in the presence of ceftazidime-avibactam can be determined using the Clinical and Laboratory Standards Institute (CLSI)’s broth disc elution (BDE) method; however, the high manual workload and significant material footprint of this assay make it difficult to implement in a high-throughput clinical microbiology lab. This study evaluates two agar-based methods for the detection of susceptibility to the combination of aztreonam and ceftazidime-avibactam, using BDE as the comparator methodology. Resistant Enterobacterales, Pseudomonas aeruginosa , Stenotrophomonas maltophilia , and Acinetobacter spp. were selected, after which restoration of aztreonam susceptibility was tested using an E-test/disc diffusion (E-DD) method, a double-disc diffusion (DDD) method, and BDE. In comparison to BDE, both E-DD and DDD methods met CLSI M52 validation thresholds with respective categorical agreement rates of 93% and 96%, and no major (MDs) or very major discrepancies (VMDs). In conclusion, agar-based methods such as E-DD or DDD provide alternative methods to evaluate restoration of aztreonam susceptibility in the presence of ceftazidime-avibactam, which can subsequently be used to inform patient care decisions. IMPORTANCE Infections caused by multi-drug-resistant, gram-negative organisms with limited treatment options are associated with significant morbidity and mortality. To avoid patient harm caused by delays in appropriate antimicrobial therapy, the clinical microbiology laboratory must be able to test and report susceptibility to novel antimicrobials or combinations of antimicrobials. The combination of aztreonam plus ceftazidime-avibactam is an empiric, first-line regimen for metallo-beta-lactamase-producing gram-negative organisms that has historically been used without prior susceptibility testing due to a lack of access to gold-standard methods. The Clinical and Laboratory Standards Institute published a broth-based method to test this combination, but it is challenging to implement in a busy clinical laboratory. Two easier-to-implement agar-based methods were successfully validated, which are more accessible and less resource-intensive than the currently described broth-based assays.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CeftazidimeAztreonamAzabicyclo CompoundsAnti-Bacterial AgentsGram-Negative BacteriaDrug CombinationsMicrobial Sensitivity TestsHumansAgarCulture Media

Stichwörter der Autor:innen

Enterobacteralesaztreonam-avibactambroth disc elutionmetallo-beta-lactamasemulti-drug resistantvalidation

Substanzen

CeftazidimeAztreonamAzabicyclo Compoundsavibactam, ceftazidime drug combinationDrug CombinationsAnti-Bacterial AgentsAgarCulture Media

Autor:innen und Institutionen

  • Department of Laboratory Medicine and Pathobiology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Department of Pathology and Laboratory Medicine, Aga Khan University, Nairobi, Kenya.
  • Department of Microbiology, University Health Network/Sinai Health, Toronto, Ontario, Canada.

ORCID-Profile: Teslin S Sandstrom, Andra Banete, Alice Kanyua, Susan M Poutanen

Zitieren

APA

Sandstrom, T. S., Banete, A., Kanyua, A., Davis, K. M., & Poutanen, S. M. (2026). Comparison of agar-based methodologies to broth disc elution for the detection of aztreonam susceptibility in the presence of ceftazidime-avibactam. Microbiology Spectrum, 14(4). https://doi.org/10.1128/spectrum.03794-25

Vancouver

Sandstrom TS, Banete A, Kanyua A, Davis KM, Poutanen SM. Comparison of agar-based methodologies to broth disc elution for the detection of aztreonam susceptibility in the presence of ceftazidime-avibactam. Microbiology Spectrum. 2026;14(4). doi:10.1128/spectrum.03794-25

BibTeX
@article{Sandstrom2026,
  author = {Sandstrom, Teslin S and Banete, Andra and Kanyua, Alice and Davis, Kevin M and Poutanen, Susan M},
  title = {Comparison of agar-based methodologies to broth disc elution for the detection of aztreonam susceptibility in the presence of ceftazidime-avibactam},
  journal = {Microbiology Spectrum},
  year = {2026},
  volume = {14},
  number = {4},
  doi = {10.1128/spectrum.03794-25}
}
Kostenlos starten →